IL-6 Receptor Antagonists Improved Outcomes in Critically Ill COVID-19 Patients – Infectious Disease Advisor

Critically ill COVID-19 patient receiving organ support benefited from therapy with IL-6 receptor antagonists such as sarilumab or tocilizumab.

Read the full article here

Related Articles